First-in-Human Trial
A first-in-human trial tested selective sFlt-1 removal in preterm pre-eclampsia. The supplied article preview does not provide detailed trial numbers or outcomes. The central reported advance is critical safety data rather than a broad eff…
1 sources - 4 claims
A first-in-human trial tested selective sFlt-1 removal in preterm pre-eclampsia. The supplied article preview does not provide detailed trial numbers or outcomes. The central reported advance is critical safety data rather than a broad efficacy claim. The trial’s significance lies in testing whether selective sFlt-1 removal can be performed without unacceptable risk in pregnant patients with preterm pre-eclampsia.